MedPath

Evaluation of L-carnitine effect in fatty liver treatment in childre

Phase 3
Recruiting
Conditions
on alcoholic fatty liver.
Fatty (change of) liver, not elsewhere classified
Registration Number
IRCT20170628034786N2
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Children with non- alcoholic fatty liver disease
Age between 5-15 years old
Elevation of liver enzyme more than 40 Unit/Litre
Evidence of fatty liver in sonography

Exclusion Criteria

Diagnosis of liver disease other than NAFLD such as : Viral hepatitis,Autoimmune hepatitis,Diabetes,Hemochromatosis,Cirrhosis,Infectious disease,Hypothyroidism
Consumption of drugs that effect on liver enzyme during last two months
Alcohol consumption
Discontinuing the study by the patient or his/her family

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath